(Q45736722)

15 December 2017

title

Enhancement of the immunity to foot-and-mouth disease virus by DNA priming and protein boosting immunization (English)

1 reference

15 December 2017

0 references

foot-and-mouth disease

1 reference

foot-and-mouth disease virus

inferred from title

object named as

foot-and-mouth disease virus

1 reference

Shieh JJ

1

1 reference

15 December 2017

Liang CM

2

1 reference

15 December 2017

Chen CY

3

1 reference

15 December 2017

Lee F

4

1 reference

15 December 2017

Jong MH

5

1 reference

15 December 2017

Lai SS

6

1 reference

15 December 2017

Liang SM

7

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

15 December 2017

number of pages

9

1 reference

inferred from page(s)

published in

Vaccine

1 reference

15 December 2017

volume

19

1 reference

15 December 2017

issue

28-29

1 reference

15 December 2017

page(s)

4002-4010

1 reference

New approaches to vaccination against foot-and-mouth disease

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Natural adaption to pigs of a Taiwanese isolate of foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Antigenic variation of foot-and-mouth disease virus of serotype C during propagation in the field is mainly restricted to only one structural protein (VP1).

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Location and Characterization of the Antigenic Portion of the FMDV Immunizing Protein

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Structure of a major immunogenic site on foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

The structure and antigenicity of a type C foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Protective immune response to 16 kDa immunoreactive recombinant protein encoding the C-terminal VP1 portion of Foot and Mouth Disease Virus type Asia 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Recombinant fusion protein and DNA vaccines against foot and mouth disease virus infection in guinea pig and swine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Isotype responses of infected, virus-vaccinated and peptide-vaccinated cattle to foot-and-mouth disease virus

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Need for cellular and humoral immune responses in bovines to ensure protection from foot-and-mouth disease virus (FMDV)--a point of view

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

DNA vaccines: immunology, application, and optimization*

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Antibody response in mice inoculated with DNA expressing foot-and-mouth disease virus capsid proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Enhancement of DNA vaccine potency using conventional aluminum adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Study of antigenic epitopes recognized by monoclonal antibodies to recombinant interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

The strong positive correlation between effective affinity and infectivity neutralization of highly cross-reactive monoclonal antibody IIB4, which recognizes antigenic site B on influenza A virus haemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

DNA vaccines: a key for inducing long-term cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Efficient induction of an antigen-specific, T helper type 1 immune response by interleukin-12-secreting fibroblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

CpG motifs in bacterial DNA trigger direct B-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Bacterial DNA induces murine interferon-gamma production by stimulation of interleukin-12 and tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Gene vaccination: plasmid DNA is more than just a blueprint

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

Oligonucleotide adjuvants for T helper 1 (Th1)-specific vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

CpG motifs as immune adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

CpG-containing oligonucleotides are efficient adjuvants for induction of protective antiviral immune responses with T-cell peptide vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2801%2900114-1

7 January 2021

10.1016/S0264-410X(01)00114-1

Identifiers

DOI

1 reference

15 December 2017

1 reference